Clinical trials
Follow clinical development from study design and recruitment through results.
- Trial phase
- Status
- Readouts
Drug intelligence / Profile preview
NTCELL
- Development stage
- Phase 2
- Lead developer
- Algorae Pharmaceuticals
- Modality
- Tissue Cells → Other Cell Types → Cell Therapies, Replacement Enzymes → Therapeutic Enzymes → Recombinant Proteins and Enzymes, Biodegradable Polymers → Polymer-based Nanoparticles → Nanoparticles → Drug Delivery Systems, Injectable Hydrogels → Hydrogel Systems → Drug Delivery Systems, Implantable Hydrogels → Hydrogel Systems → Drug Delivery Systems
- Administration
- Intracerebral, Surgical Implantation
01
Overview
NTCELL is an experimental cell therapy consisting of alginate-coated capsules containing clusters of neonatal porcine choroid plexus cells. These cells are sourced from a unique herd of designated pathogen-free pigs and encapsulated using proprietary IMMUPEL technology to protect them from immune rejection. The choroid plexus cells secrete cerebrospinal fluid (CSF) and a range of neurotrophic factors that support nerve cell function, promote neuronal growth, and may help repair disease-induced nerve degeneration. Following implantation into the brain, NTCELL acts as a neurochemical factory producing CSF and multiple nerve growth factors to support central nervous system (CNS) repair. It is primarily being developed for Parkinson’s disease but has shown regenerative potential in preclinical models for other neurodegenerative diseases such as Huntington’s disease, Alzheimer’s disease, stroke, hearing loss, osteoarthritis, and osteoporosis[1][4][5][6][7].
- Brand names
- NTCELL
- Other names
- NeurotrophinCell
Beyond the preview
Go deeper on NTCELL.
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Indications & development
Explore development by indication, patient population, and geography.
- Indications
- Development status
- Countries
Licensing & deals
Trace asset ownership, licensing agreements, and commercial partnerships.
- Partners
- Deal terms
- Milestones
Patents & exclusivity
Explore the patent landscape and regulatory exclusivity around an asset.
- Patents
- Expiration dates
- Exclusivity
Competitive landscape
Compare development programs by target, modality, and indication.
- Competing assets
- Targets
- Development stage
Research & analysis
Connect source evidence and development news to your research questions.
- Publications
- News
- Analysis
Bring the full picture into focus.
See how Gosset can support your research on NTCELL.